The new system can double the multiplex capabilities of the platform, enabling users to explore new applications, including the ability to use a dual-reporter that can simultaneously detect multiple COVID-19 antibodies in a single serology test, according to Luminex.

The xMap Intelliflex system by Luminex. Image courtesy of Luminex.

Other new features include touchscreen controls, an improved user interface, a streamlined setup, and better workflow control due to enhanced software. Improved optics and fluidics also enable designers to explore the development of more sensitive and robust xMap assays, according to the company.

Luminex plans to ship the technology to major research institutions and other partners during the third quarter and fully commercialize it by the end of the year.

Ajinomoto introduces new drug manufacturing platform for COVID-19
Ajinomoto Bio-Pharma Services launched Ajility, a flexible drug product manufacturing platform for vaccines and therapies.

Halo Labs launches protein identification instrument
Life science instrumentation company Halo Labs has launched Aura, an aggregate and particle identification system.

Synthace, Tecan partner to accelerate process development
Synthace and the Tecan Group have partnered to use their shared resources to help customers run flexible, end-to-end multiplexed purification workflows.